Detection of 14-3-3zeta in cerebrospinal fluid following experime.pdf (265.72 kB)
0/0

Detection of 14-3-3zeta in cerebrospinal fluid following experimentally evoked seizures.

Download (265.72 kB)
journal contribution
posted on 22.11.2019 by Niamh Murphy, Akitaka Yamamoto, David C. Henshall

Surrogate and peripheral (bio)markers of neuronal injury may be of value in assessing effects of seizures on the brain or epilepsy development following trauma. The presence of 14-3-3 isoforms in cerebrospinal fluid (CSF) is a diagnostic indicator of Creutzfeldt-Jakob disease but these proteins may also be present following acute neurological insults. Here, we examined neuronal and 14-3-3 proteins in CSF from rats after seizures. Seizures induced by intra-amygdala microinjection of 0.1 microg kainic acid (KA) caused damage which was mainly restricted to the ipsilateral CA3 subfield of the hippocampus. 14-3-3zeta was detected at significant levels in CSF sampled 4 h after seizures compared with near absence in control CSF. Neuron-specific nuclear protein (NeuN) was also elevated in CSF in seizure rats. CSF 14-3-3zeta levels were significantly lower in rats treated with 0.01 microg KA. These data suggest the presence of 14-3-3zeta within CSF may be a biomarker of acute seizure damage.

History

Comments

This article is available at http://informahealthcare.com

Published Citation

Murphy N, Yamamato A, Henshall DC. Detection of 14-3-3zeta in cerebrospinal fluid following experimentally evoked seizures. Biomarkers. 2008;13(4):377-84.

Publication Date

01/06/2008

PubMed ID

18484353

Exports